EUVIMEDEUVIMED entdecken
Crossref

Clinical characteristics of patients with overlapping eosinophilic esophagitis and inflammatory bowel disease in a national real-world cohort

Chethan Ramprasad, Laurie B Grossberg, Adrianna Wierzbicka, Colin Harper, Eric Shah, Trisha Pasricha, Vikram Rangan, Johanna Iturrino, Sarah Ballou, Anthony Lembo, Prashant Singh, Judy Nee und 4 weitere

Diseases of the Esophagus · 2026

DOI: 10.1093/dote/doag114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, 2026. Verfasst von Chethan Ramprasad und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA, USA. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative. Die Arbeit nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eosinophilic esophagitis (EoE) and inflammatory bowel disease (IBD) are immune-mediated gastrointestinal disorders with a recognized epidemiologic association, yet the clinical phenotype of overlapping disease remains incompletely characterized. We performed a retrospective cohort study using the All of Us Research Program Controlled Tier dataset mapped to the Observational Medical Outcomes Partnership common data model. Adults with EoE were identified using International Classification of Diseases, Ninth Revision (ICD-9), International Classification of Diseases, Tenth Revision (ICD-10), and Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) codes requiring ≥2 distinct diagnosis dates. IBD overlap was identified using Crohn’s disease (CD) and ulcerative colitis (UC) diagnoses. Analyses evaluated disease sequence, atopic comorbidities, medication exposure, symptom burden, and fibrostenotic complications. Among 797 patients meeting EoE criteria, 28 (3.5%) had overlapping IBD (13 CD, 17 UC), representing a 3.2-fold enrichment over the general All of Us cohort (1.1%). Overlap patients had higher rates of asthma (57.1% vs 36.8%; OR 2.29, P = 0.045) and allergic rhinitis (71.4% vs 48.5%; OR 2.65, P = 0.020). Corticosteroid exposure was substantially greater, including systemic (96.4% vs 66.1%; OR 13.8, P < 0.001) and topical corticosteroids (75.0% vs 48.1%; OR 3.23, P = 0.006). Disease sequence was bidirectional, with IBD preceding EoE in 53.6% and EoE preceding IBD in 42.9%. Despite greater treatment exposure, overlap patients demonstrated similar rates of dysphagia, food impaction, stricture, and esophageal dilation. Patients with overlapping EoE and IBD demonstrate a distinct phenotype characterized by increased atopic comorbidity without increased fibrostenotic severity. The bidirectional temporal relationship supports shared immune susceptibility rather than unidirectional disease progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eosinophilic EsophagitisInflammatory Bowel DiseasesCrohn DiseaseColitis, UlcerativeHumansFemaleAdultMaleRetrospective StudiesMiddle AgedUnited StatesComorbidityCohort StudiesPhenotypeSymptom Burden

Stichwörter der Autor:innen

Crohn's diseaseeosinophilic esophagitisinflammatory bowel disease (IBD)ulcerative colitis

Autor:innen und Institutionen

  • Division of Gastroenterology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
  • Harvard Medical School, Boston, MA, USA.
  • Department of Internal Medicine, Cleveland Clinic, Weston, FL, USA.
  • Division of Gastroenterology and Hepatology, Michigan Medicine, Ann Arbor, MI, USA.
  • Department of Gastroenterology, Hepatology and Nutrition, Digestive Disease Institute, Cleveland Clinic, Cleveland, OH USA.
  • Division of Gastroenterology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, MI, USA.

Zitieren

APA

Ramprasad, C., Grossberg, L. B., Wierzbicka, A., Harper, C., Shah, E., Pasricha, T., Rangan, V., Iturrino, J., Ballou, S., Lembo, A., Singh, P., Nee, J., Feuerstein, J. D., Zullow, S., Cheifetz, A. S., & Rabinowitz, L. G. (2026). Clinical characteristics of patients with overlapping eosinophilic esophagitis and inflammatory bowel disease in a national real-world cohort. Diseases of the Esophagus. https://doi.org/10.1093/dote/doag114

Vancouver

Ramprasad C, Grossberg LB, Wierzbicka A, Harper C, Shah E, Pasricha T, et al. Clinical characteristics of patients with overlapping eosinophilic esophagitis and inflammatory bowel disease in a national real-world cohort. Diseases of the Esophagus. 2026. doi:10.1093/dote/doag114

BibTeX
@article{Ramprasad2026,
  author = {Ramprasad, Chethan and Grossberg, Laurie B and Wierzbicka, Adrianna and Harper, Colin and Shah, Eric and Pasricha, Trisha and Rangan, Vikram and Iturrino, Johanna and Ballou, Sarah and Lembo, Anthony and Singh, Prashant and Nee, Judy and Feuerstein, Joseph D and Zullow, Samantha and Cheifetz, Adam S and Rabinowitz, Loren G},
  title = {Clinical characteristics of patients with overlapping eosinophilic esophagitis and inflammatory bowel disease in a national real-world cohort},
  journal = {Diseases of the Esophagus},
  year = {2026},
  doi = {10.1093/dote/doag114}
}
Kostenlos starten →